Pharma Manufacturing

Article

Pharmaceutical contract manufacturing in 2026 evolves as CDMOs become strategic partners driving scale, compliance, and innovation.

Mrudula Kulkarni | Jan 06, 2026

Article
Production Linked Incentive (PLI) Schemes: Impact On The API Ecosystem In The Pharmaceutical Manufacturing Industry

Vaibhavi M. | Dec 11, 2025

Other trending pieces on pharma manufacturing you may like to read

Top 10 Pharmaceutical Contract Manufacturing Companies in 2026

Pharmaceutical contract manufacturing in 2026 evolves as CDMOs become strategic partners driving scale, compliance, and innovation.

by Mrudula Kulkarni
Pharma Now

Manufacturing mRNA Therapeutics: An Overview

Explore how mRNA therapeutics are manufactured, from DNA templates to LNP formulation, with key challenges, regulations, and future trends.

by Mrudula Kulkarni
Pharma Now

Vaccine Contract Manufacturing Market in 2026: Trends, Growth Drivers, and Strategic Outlook

Vaccine contract manufacturing in 2026 shifts toward digitalization, regionalization, and strategic CDMO partnerships powering global immunization

by Mrudula Kulkarni
Pharma Now

Water Stewardship in High-risk Zones: Pharma’s Call to Action in 2026

Why water stewardship is critical for pharma manufacturing in 2026 and how it impacts global health, supply chains, and community resilience.

by Thaddeus Anim-Somuah
Pharma Now

From Generics Giant To Biologics Powerhouse: India’s Next Big Pharma Revolution

India is transitioning from generics dominance to a global biologics and biosimilars leader, shaping the future of advanced therapies.

by Simantini Singh Deo
Pharma Now